| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/13/2009 | US20090200167 Protein Analysis Using A Polymethine Marker Dye |
| 08/13/2009 | US20090199663 Material testing machine |
| 08/13/2009 | US20090199619 Metal oxide membrane with a gas-selective compound |
| 08/13/2009 | DE202009006911U1 Vorrichtung zum Bestimmen der Rohdichte des Materials in einem Plattenstrang Apparatus for determining the density of the material in a plate strand |
| 08/13/2009 | DE202009002065U1 Vorrichtung und Sonde zur Bestimmung des Fettgehalts in Milch Device and probe for determining the fat content in milk |
| 08/13/2009 | DE202007018829U1 Produkt mit Magnetbeads, die eine funktionalisierte Oberfläche aufweisen Product with magnetic beads that have a functionalized surface |
| 08/13/2009 | DE10207361B4 Ölzustandssensor und Verfahren zum Herstellen desselben Of the same oil condition sensor and method for manufacturing |
| 08/13/2009 | DE102008008660A1 Vorrichtung und Verfahren zum Nachweis von Triacetontriperoxid Device and method for the detection of triacetone |
| 08/13/2009 | DE102008008176A1 Method for determining material composition of operating fluid in operating fluid container for combustion engine, involves transmitting transmission signal by operating fluid with selected complex transmission amplitude spectrum |
| 08/13/2009 | DE102008006208A1 Gas analysis device i.e. ion mobility spectrometer, for detecting smallest concentration of e.g. drug, has dosing unit operable in dilution operation in which dilution ratio of through flow resistance takes finite value different from zero |
| 08/13/2009 | DE102004031639B4 Durchflussmesseinrichtung zum Betrieb einer Gasanalyseeinrichtung Flow measuring device for operating a gas analyzer |
| 08/13/2009 | CA2717719A1 Nanoparticle conjugates |
| 08/13/2009 | CA2715248A1 Process to diagnose or treat brain injury |
| 08/13/2009 | CA2715148A1 Immuno-detection of a cancerous state in a subject |
| 08/13/2009 | CA2715127A1 Siva3, its preparation and use |
| 08/13/2009 | CA2714477A1 Methods and compositions |
| 08/13/2009 | CA2714413A1 Antibody capable of binding specifically to ab-oligomer, and use thereof |
| 08/13/2009 | CA2714187A1 Methods for analyzing and removing contaminants in liquid hydrocarbon media |
| 08/13/2009 | CA2714003A1 Chk1 suppresses a caspase-2 apoptotic response to dna damage that bypasses p53, bcl-2 and caspase-3 |
| 08/13/2009 | CA2713966A1 Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects |
| 08/13/2009 | CA2713871A1 Sequences associated with tdp-43 proteinopathies and methods of using the same |
| 08/13/2009 | CA2713850A1 Biomarkers for head-and-neck cancers and precancers |
| 08/13/2009 | CA2713602A1 Method, computer program product and system for enabling clinical decision support |
| 08/13/2009 | CA2713481A1 High pressure enzymatic digestion system for protein characterization |
| 08/13/2009 | CA2713446A1 Improved peptide identification and quantitation by merging ms/ms spectra |
| 08/13/2009 | CA2713443A1 Systems and methods for ex vivo lung care |
| 08/13/2009 | CA2713276A1 Selectivity profiling of pi3k interacting molecules against multiple targets |
| 08/13/2009 | CA2713035A1 Thermal denaturation screening assay to identify candidate compounds for prevention and treatment of parkinson's disease |
| 08/13/2009 | CA2712991A1 Regulation of fibroblastic growth factor-2 (fgf-2) gene expression in living cells with the application of specific and selective electric and electromagnetic fields |
| 08/13/2009 | CA2712824A1 Siva 2 stabilization |
| 08/13/2009 | CA2711587A1 Target sequences and methods to identify the same, useful in treatment of neurodegenerative diseases |
| 08/13/2009 | CA2711585A1 Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
| 08/13/2009 | CA2711265A1 Assessment of oral cavity bioflora |
| 08/12/2009 | EP2088435A1 Time-course measurement of enzymatic activity corrected for impacts of disturbances relating to the reaction of the enzyme with a substrate |
| 08/12/2009 | EP2088434A1 Pyrocatechol violet-metal protein assay |
| 08/12/2009 | EP2088433A1 Proteomic analysis of biological fluids |
| 08/12/2009 | EP2088432A1 Methods for identification of an antibody or a target |
| 08/12/2009 | EP2088431A1 METHOD FOR ANALYSIS OF HEPATITIS B VIRUS s ANTIGEN |
| 08/12/2009 | EP2088430A1 Biosensor having 3D metalic nanowire electrodes forming nanochannel, manufacturing method thereof, and bio disk system having same |
| 08/12/2009 | EP2088429A1 Immunological analysis reagent and immunological analysis method |
| 08/12/2009 | EP2088428A1 Method of producing polymer microparticles |
| 08/12/2009 | EP2088426A1 Mass spectrometry of biological sample using immunoprecipitation |
| 08/12/2009 | EP2088422A1 Fuel property detecting device |
| 08/12/2009 | EP2088418A1 A method for the integrated and automated analysis of biological samples and system for performing such a method |
| 08/12/2009 | EP2088209A1 Methods for generating databases and databases for identifying polymorphic genetic markers |
| 08/12/2009 | EP2088206A2 Induction of the mitochondrial permeability transition |
| 08/12/2009 | EP2088203A1 Method for screening allergic disease-related molecule and cell line to be used in the method |
| 08/12/2009 | EP2088197A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 08/12/2009 | EP2087908A1 Antibodies to opgl |
| 08/12/2009 | EP2087906A1 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 08/12/2009 | EP2087905A2 Interleukin-20 for treating and diagnosing conditions associated with neovascularisation |
| 08/12/2009 | EP2087904A1 Therapeutic use of peptides derived from Bcl-XL protein in cancer patients |
| 08/12/2009 | EP2087789A1 Fto-modified non-human mammal |
| 08/12/2009 | EP2087361A1 Method for evaluating obesity controller |
| 08/12/2009 | EP2087360A2 Occult blood testing device |
| 08/12/2009 | EP2087359A1 Prss23 as a biomarker, therapeutic and diagnostic target |
| 08/12/2009 | EP2087358A2 Spicematrix technology for taste compound identification |
| 08/12/2009 | EP2087357A1 Compounds and methods for double labelling of polypeptides to allow multiplexing in mass spectrometric analysis |
| 08/12/2009 | EP2087356A2 Method and apparatus for managing glucose control |
| 08/12/2009 | EP2087355A2 Method for the detection of post-translational modifications |
| 08/12/2009 | EP2087354A1 Immobilisation and application of antigenic carbohydrates to detect infective micro-organisms |
| 08/12/2009 | EP2087353A2 Method for blocking non-specific protein binding on a functionalized surface |
| 08/12/2009 | EP2087352A2 Assays |
| 08/12/2009 | EP2087351A2 Methods to utilize invertebrate chemosensory proteins for industrial and commercial uses |
| 08/12/2009 | EP2087350A1 Compounds |
| 08/12/2009 | EP2087349A2 Assay and method |
| 08/12/2009 | EP2087348A1 Screening method using sample adsorption on filter paper |
| 08/12/2009 | EP2087347A1 A method for the determination of the oxidative stability of a lubricating fluid |
| 08/12/2009 | EP2087346A1 A method and system of measuring cetane values for middle distillate fuels |
| 08/12/2009 | EP2087340A1 Systems and methods for detecting radiation, biotoxin, chemical, and biological warfare agents using a multiple angle light scattering (mals) instrument |
| 08/12/2009 | EP2087337A2 Ex vivo flow cytometry method and device |
| 08/12/2009 | EP2087309A2 Systems and methods for detecting normal levels of bacteria in water using a multiple angle light scattering (mals) instrument |
| 08/12/2009 | EP2087152A1 Endometrial biomarkers |
| 08/12/2009 | EP2087132A1 Luciferase signal enhancng compositions |
| 08/12/2009 | EP2087130A2 Method and apparatus for enhanced bacteriophage-based diagnostic assays by selective inhibition of potential cross-reactive organisms |
| 08/12/2009 | EP2087103A1 Cancerous disease modifying antibodies |
| 08/12/2009 | EP2087097A2 Cells expressing alpha-synuclein and uses therefor |
| 08/12/2009 | EP2087002A2 Compositions and methods for binding sphingosine-1-phosphate |
| 08/12/2009 | EP2086999A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof |
| 08/12/2009 | EP2086996A1 Marker specific to an oxidation degradation of tissues containing type iii collagen, means and methods, and kits for the tracking diagnosis or prognosis of pathologies targeted by said marker |
| 08/12/2009 | EP2086992A2 Human salty taste receptor and methods of modulating salty taste perception |
| 08/12/2009 | EP2086984A1 Use of arylboronic acids in protein labelling |
| 08/12/2009 | EP2086680A2 Microfluidic magnetophoretic device and methods for using the same |
| 08/12/2009 | EP2086679A1 Container for analyzing liquid |
| 08/12/2009 | EP2086592A2 Weakly basic 2- nitroimidazoles for the non-invasive detection of tissue hypoxia |
| 08/12/2009 | EP2086395A1 Measurement device, system and method |
| 08/12/2009 | EP2086393A1 Blood glucose meter capable of wireless communication |
| 08/12/2009 | EP2086310A1 Method for detecting mastitis of milking animals, a milking system and a computer program product |
| 08/12/2009 | EP2038074A4 Make and use of surface molecules of varied densities |
| 08/12/2009 | EP1943524B1 Method for characterizing the glycosylation of sialoglycoproteins via an isoform number i |
| 08/12/2009 | EP1928314A4 Method and apparatus for measuring analytes |
| 08/12/2009 | EP1888607A4 Polymer compositions and uses thereof |
| 08/12/2009 | EP1871892A4 Device for rapid detection and identification of single microoganisms without preliminary growth |
| 08/12/2009 | EP1794190B1 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 08/12/2009 | EP1784503A4 Urine markers for detection of bladder cancer |
| 08/12/2009 | EP1776449A4 Magnetic device for isolation of cells and biomolecules in a microfluidic environment |
| 08/12/2009 | EP1763816A4 Autonomous monitoring method and system using sensors of different sensitivities |
| 08/12/2009 | EP1755662B1 Combined meningococcal conjugates with common carrier protein |
| 08/12/2009 | EP1700128B1 Method for serological diagnosis and determination of immunisation status, comprising various controls |
| 08/12/2009 | EP1681566B1 Method of selectively assaying adiponectin multimers |